Azenta (AZTA)

Mark Namaroff Director, Investor Relations
Steve Schwartz President & Chief Executive Officer
Lindon Robertson Executive Vice President & Chief Financial Officer
John Pitzer Credit Suisse
Craig Ellis B. Riley FBR
Jacob Johnson Stephens
Call transcript
Due to licensing restrictions, you must log in to view earnings call transcripts.

Greetings and welcome to the Brooks Automation Q1 2020 Financial Results Call.

During the presentation, all participants will be in a listen-only mode. And afterwards, we will conduct a question-and-answer session. [Operator Instructions] This conference is being recorded, Thursday, February 6th, 2020.

And now I'd like to turn the conference over to Mark Namaroff, Director, Investor Relations. ahead. go Please

Mark Namaroff

afternoon to Good for the today. line first Thank you everyone to like XXXX. welcome of call our We'd quarter you. fiscal on earnings the conference

issued remarks first that using after today Our we'll is our brooks.investorroom.com be located on today. during Relations' available press supplementary as earnings release are and the of the the quarter close market website at prepared Investor the was PowerPoint slides

the Private of we'll Before within There that those Act may I'd during actual results in that a we of be forward-looking of cause factors like everyone number financial from course start, identified such or making remind the to the meaning Litigation XXXX. call events forward-looking statements other differ statements. our many of are the Security to

to SEC our you on Harbor Safe section reports website, and filings the Statement, our and earnings our presentation our on of on slide Harbor Safe quarterly Form release on including refer XX-Q. various would annual the I reports titled Form the XX-K our PowerPoint aforementioned our with

these number no measures are statements should today. with conjunction to used accordance GAAP. we present in addition that with update to the events statements differ financial make We or we future financial forward-looking refer may to and Also of occur that non-GAAP obligation a data from in which results presented

the Non-GAAP provide GAAP not reconciliation but even the non-GAAP relied additional of of measures measures business. of way measures an they that an with of results to measures, be provide understanding considered more when themselves. performance, We GAAP should of upon and operations GAAP believe and Brooks' exclusion viewing aspects complete financial our the

Robertson. and Officer, with Executive is our Schwartz; Chief Lindon Chief and on the and me Financial today Officer, And Executive call Vice President Steve President

summary provide call our and have questions detailed first results quarter time to end remarks. remarks XXXX. and the we’ll fiscal provide your open from the for prepared our of Lindon will the our up then financial more outlook take look of the second on of quarter into a highlights of We Steve then will with the at And a

like to Steve to over CEO. I’d turn the that, Schwartz, with And call our

Steve Schwartz

semiconductor Mark you, off to results to to a first and year-over-year. began the we the strong we fiscal you Life XXXX. million, a to XX% And Sciences in plan. was our from We're everyone. of of sequentially on performance report start afternoon up delivered pleased quarter and the quarter, at witness to right equipment revenue in X% QX In year Thank $XXX good We're meaningful start uplift coming the market. with in that

yet we've that Our strength and we very year have QX developed the the of momentum in markets, capture. customer strong much these products supports our a to confidence as and serve another growth markets, services

mostly said, That range the we best articulate it's in coronavirus. and timing. a to you we'll how of the with what I in weeks, near-term, business, to vary Today impact address uncertainty prudent Lindon do outcomes share due and we're our to to about the of coming our that thinking the anticipate you will about

subsegments and to in made and We forma business essentially in our guidance a intended consistent we as was $XX where Sciences we'd Sciences. QX goals progress Revenue XXXX. solid order recap million accomplished starting for our Life XX% pro significant our a and now year-over-year. we give expectations I'll was of growth of came with meet what forecasted. organic showing for we quarter Life with both across

made by to business. higher-margin the and more-profitable a Sample with year-end Management. start we a our operating we progress support QX hit review return double-digit objective Sample our I'll Management, that promise of targets against In growth for to

growth and priorities terms our on for Management, Sample In we're focused of profitability.

a comment make But let before growth, gross about I margin progress. our me talk about

For most margin XX%. of of the struggled of approximately years we've gross past the get of out range couple to

pressure spending, not material undue control. Our was from performance our pricing but or that rather margin uncontrollable are operational under issues

the and to past say we've As a In management gross six implemented calls, I'm we've over now meaningful some just pleased QX, basis points organizational delivered and past another over changes that some XXX to XXXX. months, demonstrating QX, we margin full improvement said in on progress. we're XX%, above

near-term be by declaring victory which to for XXXX, that still XX% in of but can the and inside as target of to not a We're already solidly we're delivered, improvement XX% was XX% to XXXX. there's operate exceed range our much operating target we're on path here range

note, came to of the Twinbank the BX increase shipments of as well stores. automated as systems, improvements the volume large Just predominantly Cryo the from in

we're at $XX revenue quarter up line X% revenue by year. Sample the to grow our expectations. Second, in million, least this and Management year-over-year determined with X% was in

our high-value longer-term on mentioned have sales growth. will last call, capability on refocused more we that As opportunities more to and organization we've provide added our

few a examples. are Here

demonstrate that We the Cryo serves opportunity. and therapy cell continue gene to the space growth in

of and four own another added those to customer our bringing We multiple new systems. now XX customers count customers, XX

to As the It our of XX be but largest confidence and somewhat and of for have cell hold, must that momentum storage, IVF leading market an for BX we therapy gene up retrieval pick that one business, management, continue systems line for and proper engaged have institutions indicator adoption our a a included takes it our that quarter begun in will units this capability has for product research we sample Cryo innovative as protection. additional and Cryogenic of are this great company. believe lumpy ever momentum, booking orders was QX to

and on-site management service far institutions and we academic has about In oversubscribed as some we with perform their challenges. recommendations that large so outreach work been new sample inventory hospitals, a and well and to launched QX, received assessments

offering to the segment. target developed it's we has that this to our market that Investor will service you that one more confident at particularly meaningfully believe, add identified revenue of a in well but markets second are begin we And to We initiative for half, our adapted importantly, we've Day. this

for a management and patients offering, trials that adding clinical sponsors. security in sample To sample are of And engaged in and value by more clinical new X-million-sample the date, large who enrolled from sample organization and management. dramatically in a solution we we've trials new and passed and delivery samples for XXX reducing of accuracy quality than we're research retrieval pharmaceutical and improving cycles provides milestone level our handling

two opportunities physical solution Each a storage, logistics the services of need of informatics sample last inventory. these the management robust for and include for

time likely we with confidence only maintain year programs. a sequential anticipate early We to will from X/X for results and gain growth results we XX% than by for the modest guidance of again take the begin be still that will take in investments digits more the these growth bit more before more growth to growth see of target but the in to QX, we single of have year-over-year It our high but these of we'll get to QX shift it QX. back to hold,

we We our current are opportunities summarize, that with we recovery in high To started of business Management, us. were and confident execution in on-plan front the in solid position same results our Sample QX are mode. trajectory. remain exactly of we're the a QX this and by energized in

organically strong over years. impressive consistent the growth another GENEWIZ. delivered year-over-year with and in trajectory $XX up Revenue also We few past XX% quarter the was at million

few we next-generation usually was a for sequencing, sequencing and for and XX% down powered a reduced measurements though holidays was high-quality QX, still quarter with share XX% QX growth as continue growth demand some which U.S. as lighter year-over-year. of Sanger by overnight percent our delivered offerings. fast-turn gain Sanger up year-over-year service QX the is European to the from

storage build-out and of our as new is advance capacity XXX We we in functioning capability the our another Europe this customers and be lab of U.S. fully synthesis added co-located Indianapolis with facility. We and formation to main spring. the our intend in we which continued sample aggressive

importantly, Most recognize bring critical research provide. who in business continue from to helping technologies our that we new solve groups, breakthrough securing our scientific challenges customers market innovations to we

in organizations the scientific of epidemic. note reputation, Immediately, GENEWIZ contacted for And it's the global in and GENEWIZ looking Coronavirus, of community. after investigation outbreak carries was the this several by profile to international the help important the that

in continents. fully the disease of During control they've different been few centers numerous for on including three support organizations engaged past weeks,

Our and synthesizing outbreak, and Coronavirus proteins the China services antibodies. of fragments vaccines that U.S. in code of of for development therapeutic in of are of as Coronavirus the teams the synthesizing well will used and and genome, the genes numerous understanding the that other detection diagnosis production be providing as

teams who're We're to combat we trust in fully important Our around and demand this clock consider the the laboratories of this service and high fortunate the of proud engaged of and support the in are epidemic. have endeavor. contribution and our scientists ourselves to working are

on-site holidays, GENEWIZ been New for and returning the Except the that's the is will at our from China team throughout least until labs away to extended team Monday, from Chinese be rest restricted XX. February work our operations of Year

trajectory want by I Before do and that's note my significant I cell the of Life to Sciences seeing make work. about business, we're the conclude gene comments growth driven therapy

the more that from doubled. a in contribution XXXX a of of our than number XX% Although more significantly, and increases cell portfolio, we small estimate calendar derived our XX% customers GENEWIZ more gene in than grew from business still relatively Management which proforma and part year-over-year; therapy than Sample

approximately $XX set XXXX In years million come. total, looks therapy subsegment drive cell was and to in outsized to and revenue particular continued growth for gene this

the our the meet XXXX. delivering We're in change on exactly which Sciences Sample business that implementing we for commitments is structural business, expect. Management All-in our are Life results to track

capabilities team. to and We work seeing are and in new we still that be improvements. impressed the by for the we the GENEWIZ we're investments for we we performance to continue well-placed have making geographic Similarly believe are strong dedicated and work do And this of doing expansion. but

than who to share equipment. the to quarter-over-quarter a of once also lot design ago. from dynamic serve again wins we of had XX% $XXX another as new discuss a was We quarter We gains revenue adding exhibit by companies market up higher Semiconductor next-generation segment. continue have million different other quarter QX side the one XX this same year process X% into and strong on

quarter. QX revenue these significant of the another is QX, more value this which our also levels we product deliver was portfolio, that new which point XXXX we quarter, is semiconductor What's of record that was the of to in in our are levels and the unique peak is at June essentially equipment market. We it delivered poised the highlights performance. believe fueling peak

and high nodes. revenue watermark product for CCS foundry spending adoption records powered These by critical are device

for remains also well-below even packaging and not peak benefits spending, our have advanced automation the robots more demand drives memory of levels. yet We which and systems seen

packaging advanced point to The return recover, and have or is fully a records remain relaxes a set to if new before headroom even we should do bit. spending they we strong still prior revenue even levels foundry memory when

different is We have a track semiconductor many our sweet allows position very from equipment each outperform which share supported robust on area and to strong we're market. technology trends us and again spot, the benefits once by

business our automation, and color some from contamination specific major give I'll packaging Semiconductor solutions. control drivers, tool advanced

now automation squarely our business. are is in still X September. quarter We more the OEM from than in our And with an although peak, consistent the prior you've the approximately sequential to Tier XX% forecast on wafer of in and We heels middle a grew in is vacuum robots growth our of XX% increases upturn June sequentially this about. of robots XX% revenue March we lower increase heard the anticipate automation

million solid flat the market to a design this was for modules QX for position new packaging market. lid nonetheless, soft continues automotive various $XX market on new packaging in XXXX wins advanced automation keeping six with had as keeping us at Advanced with develop. We,

million broadening base shipped to food was foundry of XX% and and a the September, million our of we're Solutions foundry. compared up share of a we we've the in business. Control that the late in you ramp December beyond still jumped but applications and $XX to were Coming had X-nanometer And with quarter quarter much for quarter Contamination December the with off to that's volume in $XX about of The customer cleaners one installations, X majority ago. year for record seeing

yet all all In who in penetration for the QX, technologies the were market more technology to not CCS just at adopting who five are now customers These signs node. we customers XX-nanometer new our extending opportunity. future promising added Asia, are another

another for the March very for outlook business same approximately is Our the QX. in CCS at levels quarter as strong revenue

cycle. these market If way We portfolio we equipment; grew semiconductor for We've one down while and leave from times and it's peak report Semiconductor technology and a a a is which with you still now, takeaway valuable in was product our the the this. in in in life off. a unique constructed semiconductor year XXXX, long

is ago, We are phases secure peak early business XX, The X-nanometer we a revenue nodes during we levels. stronger. business at design position the is X that and our have today technology historical of and won years and getting

the much design, design production perfectly mix. close more their approach design of remains perfect that today, process same an with and there years the are the technology down lock to manufacturability in R&D way, same, we capability. we're future OEMs and securing through Only many the Our a collaboration in build in volume leaders with collaborate partnership today our advance win Then cycle And fits step. global a needs and our activity. production solution top for automation partner

a of growth in opportunities. XXXX we in to we this one best capture ensure we've from to started for sectors our results what that financial and environment ever from in market We meaningfully we're these and deliver year built. our to executing which be the all the strong continue look We more

my over Lindon. call the to concludes formal now and turn That I'll remarks

Lindon Robertson

key Thank to our Steve is of saw quarter XX% starting acquisition profile the positive includes website your in highlighted. the the a with refer business our fueling in you, the on as cash of flow. highlights. year-to-year Life in margins has the XXXX which The Steve. with and growth starting a Slide addition growth, quarter slides has and I'd GENEWIZ, each the to X supported to growth effect Growth attention portfolio higher which We in like Sciences, occurred been final November of acquisition. of with

is We X%. XX% The year-over-year. was up that now than decline business Semi organic Management year-over-year. higher ago. to year-over-year experience CapEx growth The Sample X% this XX% didn't X% ramping returned growth showing years grew two expected most of range we've also and is quarter and up a that GENEWIZ sequentially again did also peak, as in but is Semiconductor XXXX prior companies the which for we XX%

period control to The large of robust contamination our shipments increase customers. chip from from manufacturers and of record vacuum in the solutions this growth momentum to shipments came OEM

in EPS gross We had with – driving XX% Sample year-over-year. in and margin performance around business. centered growth non-GAAP are profile The which Management GENEWIZ revenue highlights the in business, our the growth the EPS growth the each really added the improvement profit we

The driven in from operations. our first million Cash quarter, we $XX out fiscal cash flow compensation cash where XXXX, strong of quarter flow flow followed we continuing for from million strong pay quarter highlighted operations from fiscal variable when was and our operating the of this a this prior was adjusted $XX year. fourth the

acquisition if ample million in and transformative $XXX materializes. cash investments, taking for next cash debt approximately With net for and available available we smaller have operations acquisitions capacity when sizable the and

reporting company share ago. improvement the $X.XX for operations both continuing one and $X.XX on basis, we're operations On to total depth. GAAP move basis. earnings overall Let's quarter an is in The and in in Slide continuing to from from $X.XX P&L review X a fourth the year per

basis. non-GAAP non-GAAP both the year-over-year. basis, and gross right side year-over-year on and $X.XX revenue the approximately the stable same a as With have total to comparisons, were of the the EPS, page, On a we the improved growth reported prior the of on $X.XX quarter sequential strong over margins

margins. and perform different should better. had of Sciences' However, consistent or with our the at for This this a comparison dynamics outlook the and this long-term Life basis XX XXX trajectory there basis improvement level are we in The significant continue modeled year to points point is reflects segments. in year-over-year improvement within the gross

a point XXX less Tier decline to reflecting in of picking and Semiconductor the significantly in Tier margins, see shipments by affected in saw rise the mix gross half. basis We to second revenue OEMS. up We X a OEMs second-tier the the X

for revenue Sciences. by of quarter, XX% fiscal For this quarter first was driven the the Life

Life Life Sciences in lifted So, the upward toward and the the of overall. strong performance company Sciences mix the increase margins margins

year, a moment, on of year ran over sequential acquisition is investments. of GENEWIZ margins a But with related the course I good we its net expanded you income and the a for the over evident into progress EPS. in headwind. Operating expense the to If take and bottom-line naturally there the basis,

us and XX-K. to address what legal But the disclosed weaknesses approximately additional primarily our we fees, held back from audit progress showing material in the $X some expense quarter above million service we of of was filed to Form in professional December when fees related

and the us less million down behind We be $X second in expect of come this at end second will quarter. quarter will than to the the

expense year have debt for rounds to acquisition, came expense associated down ago non-operating carried zero the but with no that we significant quarter. to the A we interest a the million ago lines, from In GENEWIZ $X longer year burden. what

the tax for jurisdictional The higher is higher year-over-year the rate the three about and driven XX%. quarter. points non-GAAP mix points than primarily higher income. This rate fourth was The is five our quarter about of from

to continue for to XX%. year in be range of fiscal rate XX% the expect We tax the XXXX to

In XX% up XX%. EPS non-GAAP year-over-year income and total, net the non-GAAP increased is

item will quarter. $X.XX and on flat emphasize of While in March the professional earnings the $X.XX of be $X.XX, earnings in put end fully QX behind is approximately at the pressure to essentially that the to at the sequentially and fees lighten I I increased expect us by this quarter the

to one-half acquired provided for XX% in Sciences $XX the million, GENEWIZ the year, November of XXth, GENEWIZ of growth starting you year-over-year. I we remind I'll quarter. XX% with organic business on as came own GENEWIZ the the million that QX in XXXX. segment revenue last Life we quarter Life was will first Slide $XX from and up results Sciences. X, our revenue In Turning discuss quarter,

X% The year. consistent Sample Management of growth start business the with the expectations provided organic for year-over-year the slower

stronger the bring We expect us this full to approximately upward X% the second with in year. to continue to half growth to trend for

a forma as invested the and we And the the in are Management XXXX. Steve for higher full and pro see second Sample year-over-year. in segment On to calculation pipeline XX% into growth the engine total outlined, the some have strengthened in in for half grew quarter, fruits and beginning sales

Operating for expansion. margins are on clear a path

the is holding I see be can here that the progress line, segments this expense from margin operating similarly the second the is results. both in will of and the progress we You the end to driven the gross back some of pressures expect clarify which quarter largely by affects bottom resolved by quarter. margin

Driving driving this performance and of business is another Sample basis of gross points year-over-year store full GENEWIZ. Management than the XXX points the more which margins basis systems. large improved Sample indeed margin systems also and a growth saw the of benefited we improvements in Management improvement that the the of of store Twinbank Cryo in on product BX Management from improvement again performance the we sequential mix from business. XXX was lines our the Sample of quarter of benefit – Inside quarter

in into also impacts second we which quarter, operations Science the have our may coronavirus the but Looking revenue the and caution see business, China. on momentum on of some take the Life

Life our GENEWIZ on has be for our guidance team shut the million revenue China light second week. down supporting are we has broadly work of While the been to some GENEWIZ Science in a allowed request This million. portion primarily had to until quarter this, business. the next in inside virus, to ranging for China In market battling the $XX critical $XX our impact has of

can we China million constraints then end If downside the coronavirus, to million. assessing center the Let the lower for range the guidance, impact that at explicit the in some the the the the of where this. accounts of the million than $XX The a impact in about market end The $X event from would longer me expected. problem $X the more top the midpoint range momentum of toward guidance the our be constrains we of business is China marketplace. current recover center

are an Semiconductor year-over-year. increases X% strength systems increase The are six. of carrier in slide XX% in was revenue and the wafer Contamination coming our the in point to Solutions primarily Tier $XXX solutions, primarily X sequentially million robots, and vacuum turn first continued increased Control shipped OEMs. this cleaning which to demand at Let's from quarter, to

included benefit any increased This the ramp of OEMs. second-tier shipments has not system to yet

XXX does QX margins, time basis a anticipated As mix sequentially. of at the which gross this downward on have segment down guidance, our the impact product points was

systems the will and more the expect to pick through improvement which margin in We broad-based year. support up second begin to half, demand vacuum

Overall, impact quarter, the to in million. to of our the robots continued are situation the the $XXX into in the revenue expecting systems X coronavirus a assessed and not million expect to we of Currently, on QX second to see are Tier Looking semi performance. pickup we OEMs vacuum business. and we have range have strength seeing $XXX significant be semiconductor

to the continue daily. We monitor situation

seven flow Let's million a the of summary flow. cash over cash operating slide cash free of our now of flow million for generated quarter. $XX We turn and to for $XX

As referenced quarter flow cash earlier, an fiscal is the strong first of year. our exceptionally for this

in flow million Suzhou, marketable cash facility this securities for expansion the the The in quarter past $XX the initial than $XX have months, XXst of China. million our primarily $X CapEx Over to driven of new $XX $XXX in cash million, quarter, operations less generated million start total by million. investments of the and from GENEWIZ was as to total amounted the bringing December operating includes we operations. continuing approximately and six of

you summary will of the balance see a sheet. X, slide On

of at column. see can marketable cash ending balance million You the and December securities the $XXX top of XXst the

tax obligations business, the Semiconductor January. paid in on of sale the we liabilities $XX If you for which scan Cryogenics down the include current of column, gain million

of see $XX of also debt. total can You a we million have

of debt, the adjusting approximately taxes $XXX paid and by cash for cash the investments. the have million by So and balance we net operations

million. share. to to share is to to $XXX quarter EBITDA be range million be of $XX of is slide our per on for the up Revenue with I'll earnings non-GAAP Adjusted expected to in $X.XX $XXX to $XX be second And million now XXXX. fiscal diluted million. per X anticipated wrap the guidance $X.XX

in environment have to China We work for of most is that coronavirus the with economy factored the in current expectation mid-February. China the back

this year. continue XX% for to to to the addition non-GAAP rate In also expect tax XX% guidance, a we of

concludes the This and to our the remarks over I'll turn back take call the prepared now to operator from line. questions


we you. [Operator And Thank a Instructions] with from line Paul Janney go question Montgomery. the ahead. Knight have Please of

Unidentified Analyst

for quarter. Hi Paul. guys. Mike It's actually Congrats on on the

Steve Schwartz

Hi, you thank Mike, very much.

Unidentified Analyst

So on see the talk sample -- most Steve to Can actually for X% management what year? the side, guys that's the and been that obviously a you been other growth confidence full in of of gives we've continued the kind seen. can quarters ramp-up hit that and kind one to visibility that the has volatile just the the you

Steve Schwartz

Mike Yeah, the had some Sure. of volatility. the We to you right. said a think group. lot I We've internal exactly done it stabilize first operations

couple and capability progress think focus sales on just some making added a about. We've that initiatives there. good really I we of talked of I

samples, Sample good our Sample clinical meaningful booking will Hub tools And levels we the Cryogenics capability. frankly traction back the success. the the We be that's see on delivered spot traction, and good sweet One Management business. year. can started to The trial in significant. call are And real to those through have

some tools get year. bookings sugar a not We high. out the we'll distribute through the it's and So

some So good have we pretty there. visibility

we that we on aggressive to that that too working to miss so will anticipate contracts we're frankly on And the want don't and not we're We've stay, the got we in on hard just timing there's want left. because some timing. bring work

a that visibility if like. can see pull but look like and customer bit So contract a work to more I started we half But good of into the what It of quarter, activity. will think year lot to QX the like. we have build again, looks into what current of little we're crazy about backlog some in back stuff the and confident QX the it's

Unidentified Analyst

just to and Thanks. you a to, result are then you Life base? GENEWIZ front, executing GENEWIZ there. such like just Thanks. And of Science quarter of guys great kind on with or a is Can customer talk and see it just a business kind the being starting that record synergies acquired, business looks of that result a some a combining your you of,

Steve Schwartz

is I credit outstanding a trajectory. that were want take for and Mike, and they full GENEWIZ But, team, doing. it's Lindon everything to an frankly, on

So They expand, to they this the knows thing win do. capability, customers they capture they and GENEWIZ is that developed business. how

our think allow beginning far been place. haven't In synergies allowed there the so laboratory constrained significant of of and has And, take regional that I New to that here a in modification expansions expansion to are NGS. contribution we show. some pretty capital frankly, Jersey, we the the of we've did of to labs, some are some the of

We started think customer exchanging haven't the one both real opportunities talked businesses. there to that synergy by we two much is, we And the business that meaningfully, we're things see the organizations and leads transmit about there. of too things team; now, between contacts Sample starting Storage and and are help GENEWIZ between the

there we parts both organically. us. of we're the promise in business. our make are desire in. business, hope capability we of now, the energy that having a closely teams sides what that of together, built to more both has it's benefits and lot think by benefits to kernels of that see putting right but we're that GENEWIZ accrue starting great We And, to them accruing can is again, are the to So, our work And do and sure the doing think for

Unidentified Analyst

Thanks Appreciate it. guys. for the time,

Steve Schwartz

Mike. Thanks,


with John from question Please next ahead. Credit go is our And Suisse. Pitzer

John Pitzer

for questions. of side business. on me the Yes. Good Thanks afternoon, just the guys. semi question, Steve, the ask letting I first guess, my

company-specific had of XXXX, You calendar excellent guys drivers. some an year sort with

calendar to that are two look out different and out look front you've guys the we somewhat As of give at out just forecast the XXXX views. end and there, WFE come had kind

in as kind drivers? think kind the more XX% how context that of, of, closer other, do just perhaps spending But company-specific in growth much XX%. to environment? importantly, of sort potentially year-over-year backdrop about I'm the just how about WFE; of the as talking One some of we the growth your with curious, you'd characterize,

Steve Schwartz

Yes. But growth best are That's just on that's things the rate. for content let growth one every those board drivers it's our white that day. The are couple of happening general or my Thanks XX% me our of in things do A John. exponential, content have business, whether XX-nanometer XX% from up. I Control node and to much to of X-nanometer, the won't in say certainly when but And Contamination device ultimately we continues how many and go multiplicative the how it's for tools content it's to X-nanometer, to terms foundry, shrinks. here. X-nanometer

spend from of one level necessarily. to business one would to consistent the next, the node foundry year next, our from a even Just increase but

flat if example, for level went X-nanometer as but an they put they a for be of So example. from flat from at cleaning X-nanometer, CapEx tools an a more spend us, the our TSMC, increase in, to because spend, would

spend the XXXX and deposition By higher had token, the device complexity the is grew. we environment those the of of higher in etch we in -- count a same where so down sophisticated steps we semi XXXX, more and processes process that even technology lot saw number a the vacuum really of XXXX, for vacuum timeframe steps for content, what a

trends are those So continuing anticipate that into we XXXX.

it's number, if XX% or outgrow reason. If be that but to same XX, had anticipate that. the said Having a it's I'd we'd it's you we'd we outgrow that, tell we if for hard-pressed XX% XX anticipate,

John Pitzer

So perfect.

that compares again? of prevents mouth outperforming just to despite you put from harder not your don't year-over-year you words year, last year performing but the So in this think out

Steve Schwartz

that's question. John good a really Yeah,

would the a high high-end and spend, level more be we weren't foundry, of Just we between probably things the gives still us industry of confidence. and back because would how gap We -- than have it, fell be industry. foundry performance. about that. be If closer relegated lot we probably wouldn't foundry were such our anticipate think to we'd big a we performance higher to It's the off that we -- it

John Pitzer

I uncertainty are leverage the That's there I'm regardless? will being up the any if appreciate guess the only guys revenue a the trying more curious, or the in helpful. or you've And it is in quarter on curtail revenue uncertainty show expenses the doesn't if of the just some quarter just then to to kind around in sharing uncertainty, match semi business? lot March question spend uncertainty, you I thoughts. earnings? is you of embedded the coronavirus, is And you revenue virus

Steve Schwartz


look it it We our for like and the quarter. So supply feels chain me covered try way. John let we're this at

And don't have pretty that so anticipate managed those -- we would we've impact, do issues. are We well. but we things think that China

to who puts The an for can't subcomponent They product reason. be a ship shipped. fab reasons is didn't our robots get couldn't chain a would for if if OEM they thing account different part supply critical to supplier example for may a take not the take other tool that they into tools of a need if had prohibited able another suddenly for who we or example not

our based now, forecast look pretty on right semi But solid is how it. at we

couldn't But don't open And so then have impact. coronavirus, on we components their we an OEMS to there our is close chain have a We if that would customer base that have the but paying on are risk would had a in an with much supplier trouble couldn't secure. that supply fab And attention. another get impact take supply think us. built if hedge shutdown and tools

John Pitzer

question, pure last my just then And Life question. Science a

quarters. done last the You margin guys gross a good job on over have the several

You you And get period? time that drivers talked the wondering, if can the to we how that linearity from here just XX% there talk about by about I'm you think about to should over XX% there? XXXX.

Lindon Robertson

is know as you here. him well. Management Yeah, pretty so to And in as Sample chime John option I'll give I'll nowadays, chime managing closely the in Steve

as primary just our is margins. quarter mix we a was of And on this the natural last said help one, year-over-year. GENEWIZ growth a really of twofold; incremental is the the driven acquisition benefit due contribution gross -- before the But dynamic to of

full be Next year-over-year a full year compare it quarter this that's mix. will GENEWIZ has benefit. at -- next so on But nice the be growth a trajectory, faster will mix been it a a XX%-plus

And cost more fair around performance labor shipments, been quality the we've is and out. step the is around significant. impactful that cost of where steps. able stable nice this in much. Management. the not to is of more been and but so product amount take largely a some able shipments services function Sample been opportunity equally management it's see and/or cost and cost Inside product And includes project -- Sample of as quality the we've and materials, margins. But pretty of those to this Service Management, more But has

past influence I'll strength highlight business in development head semi we the had Cryogenics-based already from that, Life as quality, we've our a years, take senior of disclosed did who semi were especially, business Sciences before, as helped Steve when the stepped business. in, the building the first we from to development executive of the our

and semi still actions, seen impacts stepped there his It's opportunities on of the Management laying be gathered. he's applying those But in on and quality -- seen there's we've more but now Sample to the already side full-time disciplines. already

So systems benefit to the Cryo a really most happened got that we system. significant the And reinforce then as traction. we're is improvement called, in what we ramping notably. is another see But we nice systems, BX more large what and this

and from That's on business not and the cost improved just margins but from really that mass much a of size. coming critical issue, so size that,

both -- that's to are isn't territory we these a in to of to expect us. And us. carry foreign continue this So completely help

XX%. been struggling here, We had in for think, ago of XX% we've I with this. rest year I the confident XXs, feel say, should three-plus and above years trajectory the the -- above been being we've we above really But,

XX% XX% and year. As Steve to seems us XX-plus next reasonable getting to into going we highlighted, pretty for struck

John Pitzer

guys. Thanks,

Steve Schwartz

lot, a Thanks John. Yeah.


B. And Riley we Please go FBR. with a question Ellis have from Craig ahead.

Craig Ellis

the follow-up for start. Thanks wanted on earlier taking some of appreciate semi questions on I Steve, Yes. to the I that. to questions.

it content the gave X, the example when increased talked maybe some in the you X, CCS, directed and you et intensity. the of just strength was about business at cetera, First,

or foundry business a that strength increased front potentially seeing we memory we've XXXX? see something Clearly, and some related the you're the is in now. of and that your strong the very still in yet business that and sense is got logic to spending environment of spending memory, Is later in XXXX

Steve Schwartz

Craig, Yes. thanks.

right don't much on all CCS heavily moment at it's spending we sure memory. foundry from now. For at see the this side, And

that our to automation though some vacuum from memory, it's And anticipate are difficult that of so, We but systems that. the we'll conclusions tell. draw shipping for do we're us from

foundry, but CCS the now customers. said However, pretty is different base more XX for products having the than that, a customer part significant is

anticipate spend. And from the significant when still so, now, the of foundry from pretty our see start coming maybe, into But, shift understanding some we behind that's foundry that memory goes does we'll pick logic up, right is memory. -- to

Craig Ellis

about And point you CCS's you feeling at a XX-month period? Steve how as capacity to out XX over are this look

Steve Schwartz

We're meeting base, got made some up extremely through supply at picked a good little We've probably we're If us kept growing you'd hear not good the they've we all. constrained pretty contract up partner on pretty business manufacturing a good it -- ramp XX%, and a well. side bit. and

We have we -- I frankly levels that advanced preparation a good. like think ago, enough this, we had wouldn't year pretty anticipated in look but feels

need need moment the capacity So thinking of able do if some you're quickly. feel of get next quarter to what add more do current to kinds to it we ramp we're to quickly. at But a anytime not breathing we about to we about systems. this, covered you do and room a the to levels? you think like have this room well you got these gives us. the be have And it it But find really can't hit move, to a way always at the like do when have or as us levels we've bit will there's threshold you to good We that a little

Craig Ellis

about bit And Thanks Got that investors about the that's things on it. small, that just us point the you to cell is gene from doing And grow for million should quickly? then and clearly therapy switching front giving is revenue bigger the think Can Life last potential year. the that a $XX little in Sciences. more base area? Brooks getting multiyear to data at talk it's of but pretty how in company a

Steve Schwartz


the couple So you starting one to there'll from Cryogenic a that some you of the research points see I'll Sample here, we the same side, Craig, the and couple give there of a one We're I'll and the side. of do convergence customers be data side, and the of from satisfying give Management system interesting. ultimately GENEWIZ it's -- side opportunity, anticipate

call developed that a it is the particularly proprietary to bit I smarter who construct about mean technology don't things and GENEWIZ it's proud things through. working recently and that if will but and gene to sequence of AAV people extremely a little little has One lot to means I a that of sure a some to we're a you, of related to space the are therapy which an But the it other more get people that's research Craig know cell the is really as for it. in necessary virus me ITR, I'm doing hard on and among particular this make to will

been which of on construct means it they last the it's proprietary summer by they a has launched the GENEWIZ lot has enthusiastic and customers is overwhelmingly positive. therapeutic unique continuing that's the the we and in accomplished But reception virus recently A construct China something And just the industry. by a into And delivery this of extremely can and and read beta out acceptance Europe and to beyond this people the come see has and U.S. participating rolled GENEWIZ. been to their we strong.

not spent billions And be, us talk control for focused this on that cell opportunities research the has dollars it's capability. When and are initiatives in you and we the gauge space. see of it's about when support hear to imagine of team therapy. gene to for do GENEWIZ disease the how on being big know but might research we how centers are and who tough the of incredible the customer this GENEWIZ, us And capability around that for us know it's about capture, just the

wouldn't you mentioned tell ever to sequencing the people heard it, complexity sequence you they excited about necessity it, about space, capability walls around the really of to the ability the the AAV But if And talking would this all ITR that. GENEWIZ know can you inside and about of really and people of still company, of it the that we're team do. about that And in it. through like proud

understanding about some a the science getting we're on Cryogenic The the again, other one of and to is this activity. talk what's where, And is, closer I'll cryogenic necessary. the lot side,

building so, we're as well. scientific And capabilities new Cryo inside team skills and the

their make these the to are very a one the products continue of quarter, a – who customers cell gene to configurations therapies. have product approved progress and market. support CAR-T line that a shipped various it's and with to leaders first in we the follow-on and store and customer they the their the a R&D, immunotherapy to their and strong store in in second for of We therapies in manufacture control But interest first whip quality

And research road there's therapies of R&D down why so, construct and that's what chain finding an important of this expansion cold going that, what called a we're are what systems. one, the a there's is in do although, the manufacturing are autologous on early just, related a lot next-generation products complete standpoint, these to how allogeneic cycle? an really And from I because it's do I to manage from do that's immunotherapies, Cryo

terms just need samples, in of they of the develop they begin that maintain so handle handle they'll the approval sample. the but to that not to can GMP in means from them, FDA what's People the need the how get to maintain their – to terms

and we're excited we're So enthusiastic.

considerable And the right and that a the we'll to call, growth the company. don't -- it's see gene we therapy Craig, hard-pressed upside. you others the we necessary considerable better in job formats has growth as significant development full forward, to you. the that But these from space but they for put I done. need, are small see we that and be what's across demands let on a do the be space. it, and to pretty think, in anything report are I'd one we and they company, on to number Each we're give to we of doing think, cell go attention But customers the try and test a about but going to we be upside in have, how this try initiatives of we'll center them relatively us need know noted you to on as who the some from

Craig Ellis

helpful. we've That's segment quarter-on-quarter, queue, before growth then that rapid one got I in and we're back coronavirus dynamics the last unless isn't flatter Semi hop risk Lindon, there earmarked. as the in look Sciences, that the I at Life And you've

just the can, downward to like not seems basis, then, it what on, June would a a at margin? takes a segment out if margin quarter? there drift subsegment talk on going in in And gross what's be you the you But basis, I'm can but you puts sure look you might gross Thanks. about as and see

Lindon Robertson

the Sure. I Really, would now, right center we're margins approximately I sequential guide in think, on a of that basis. guidance, our expecting stable

what much as this our semi When levels seen in back, backroom up, we we've we're while systems, come that comes broad-based It's gross to the of second to quite not systems. expect for in margins Semiconductor, starting that in back we our fiscal year. to the as not last half year. expect it's those example, see to pick So in

of the in the bit gross – impact in benefit in of bit China – a I overall, on Management, operations. And and there in little question space, on margins. on that I And the little there's the flat, expect carry of GENEWIZ stable is our a terms additional Sciences on impact here, coronavirus benefit we just Sample have space while the above think, a in Life to financials we're counting

I think margins. don't responsible right you being the that given we're we've now conservative, flat the being as describe So guidance in want we're to around -- it I

Craig Ellis

Thanks guys.

Steve Schwartz

Craig. attention the Thanks Appreciate


Johnson have Jacob we Stephens. go from question a from And ahead. Please

Jacob Johnson

taking would I Indianapolis interested be for latest thoughts question. thanks the the your in Hey, facility. on

where I interested capacity capacity be being Just XX% weeks couple expansion utilized of is think you a how much announced And of a ago kind today? stands currently?

Steve Schwartz

a gives space The last of the we're it it what's footprint. park the space expand step rights this had certain That we've reinforcement owned And caves footprint and the up beginning had the additional a phase airport. the includes until right us the just and I'll to we that the And mean, call expanded our context in And part. is XX% one happening of of is warehouse around a and increase. is gathered. it nice out I the into out. made to Indianapolis to happening in industrial since and in the in Put in this want had of fit XXXX, when it that time context. we electrical site. the put in about But it's we doubled warehouse investment that building. we And near we've -- conditioning next it that in pushing Yeah, storage the I fit the or of we air have more industrial what's it

is probably an growth And on the annual we that reflects this so and consistent basis see. step, another

the step often this samples we that I'd before in don't this highlight a I take described week the but And have in. variable of freezers as up, CapEx. see this We in investment we fitting until coming this put

up. few put as demand that generally we coming freezers in the in set is a we have So and

empty it's of It's electrical freezer I call a that racks shown, in a of demand. very some So of that's just variable just the it have don't for have empty long. for ahead why -- freezer row CapEx. right drop harnesses you few sitting it's and I've ready in We but idle just a seen photos

on attention your appreciate side that I So releases. marketing the of

Jacob Johnson

like quarter that and second back just put From year. then And second have XXXX quarter the I'd question, plays just results half other EPS got any you one. that particularly the we of But XXXX just together, implies it kind loaded be curious for it we think a out one Thanks your guidance, on into line? first guidance half. visibility some on as how you've thoughts sounds about EPS strong comments, a additional

Steve Schwartz


number that the there's the we is So think for nothing or have that of trajectory point viewer we takes year. off planned crossed that us one I seen

time back So happen Day through saw remarks, to going prior our we just indications had the always that what -- to Investor I'll semi our if over you of go highlight was had we discussions from the September, groundwork good in would and sense control, load all very additional order customers. a we -- would we for around gave us and strong happen on a contamination our on what that verbal other

to the generally don't we half on until while was first so semi, contamination come were that in going quarter orders before us And a X well. to in write December market start September indication gave the and that the pleased starting, And control. the OEMS, the as of everything really see it were in we strong which again hearing ramp would be in then in confirmed the Tier of you

be And meanwhile, back comeback, a coming tip the half, more on didn't March exactly that second systems of half hold, would you we anticipate first also is what's up it the start business, in shared inside with be and happening. quarter would this possibly to we that this

have we So that. in confidence

that profile the other back, of so, Contamination as Control, both And business, Systems, in second business in do questions, the even included coming around Customer one comment, little we gross a I'll robust improved margins -- more because leverage that to more in I with especially again, see margin the half, growth. the in the Systems broad-based will business but us and broader with provide and Semi

believe the outlined the business, that Science the to very coronavirus significant year, XX% have hesitation growth for GENEWIZ continues that not we're true, if hesitancy with the Steve which for year on with the a a the second this year. perceive holds very the Now on reasons given encouraged a a for caveat significant Life be in of quarter, and we pause, will

ITR strengthen critical the business these some relationships momentum us developments an was fact, of more some -- the the AUV more in gene the capabilities that of and expose organizations helping level. and some upon the institutional actually relying actually And, that we is at to seeing by of highlighted heightened are that CDC nature and he of the engagements

So momentum. we're encouraged by that

nothing there And so would change.

it quarter. really that we home I Sample had on hammer the above on is track. average that Management, the first on the margins even gross for and in for the year And then here were objective And

in So as expect. in margin solidly That's place, you more control. profile our is would the

the around very some to Influencing the the therapy highlighted the and opportunity BX Steve and in around demand, visibility encouraged of in half. so Cryo developments, the developing had line see is we that cell momentum. and and of things we're pipeline traction that have other second we've it producing And opportunities particularly on sight gene

get a the we OpEx I everything couple far really is in talked little We about. the that a half with any first second to more half the trajectory than so have would yes, We'll double, to So the I reason expect the hesitations. of have have had that dealt on model. behind back to done. liked One, But, I off we secondly, don't so coronavirus; here us.

Jacob Johnson

Got Lindon. it. Thanks

Lindon Robertson

you. Yes. Thank


believe, that's questions. back CFO. all the we I'll for time Lindon I And, call Robertson, the to have turn

Lindon Robertson

interest you see appreciate Yes. that active him. but and and as And well us Thank for here, out we Scott. invite day to Namaroff in we the that. we you very the so welcome immediately the get. much, after to every significant the We and introduced family. calls reach attention of a And we interest our Mark he's calls always investor with amount call

and you IR next the to now on but quarter, look the next contact find forward through on can between look forward his to certainly we website. you And our You call. seeing seeing

thank you very much. So


call ask the your for disconnect line. conclude your participation please We does thank you and that you That today. for